| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Endocannabinoid Blockade for Improving Glycemic Control and Lipids inPatients with Type 2 Diabetes Mellitus |
Hollander, P.; |
The American Journal of Medicine |
2007-02-01 |
查看 |
| Endocannabinoid Blockade for Improving Glycemic Control and Lipids inPatients with Type 2 Diabetes Mellitus |
Hollander, P.; |
The American Journal of Medicine |
2007-02-01 |
查看 |
| Role of the Endocannabinoid System in Regulating Cardiovascular andMetabolic Risk Factors |
Woods, S.C.; |
The American Journal of Medicine |
2007-03-01 |
查看 |
| Therapeutic Options for Modifying Cardiometabolic Risk Factors |
Aronne, L.J.; |
The American Journal of Medicine |
2007-03-01 |
查看 |
| Role of the Endocannabinoid System in Regulating Cardiovascular andMetabolic Risk Factors |
Woods, S.C.; |
The American Journal of Medicine |
2007-03-01 |
查看 |
| Therapeutic Options for Modifying Cardiometabolic Risk Factors |
Aronne, L.J.; |
The American Journal of Medicine |
2007-03-01 |
查看 |
| Understanding Metabolic Homeostasis and Imbalance: What Is the Role ofthe Endocannabinoid System? |
Kunos, G.; |
The American Journal of Medicine |
2007-09-01 |
查看 |
| What Is the Potential Role of Cannabinoid-1 Receptor Blockade inGlucose and Lipid Management? |
Jensen, M.D.; |
The American Journal of Medicine |
2007-09-01 |
查看 |
|
|
